Screener
AnaptysBio, Inc. ANAB EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by AnaptysBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026. Open the filing →
- Filed
- May 12, 2026, 4:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219515
FAQ
- What is AnaptysBio, Inc.'s EPS (diluted)?
- AnaptysBio, Inc. (ANAB) reported EPS (diluted) of -$1.84 in Q1 2026.
- How has AnaptysBio, Inc.'s EPS (diluted) changed year-over-year?
- AnaptysBio, Inc.'s EPS (diluted) decreased by 43.8% year-over-year, from -$1.28 to -$1.84.
- What is the long-term trend for AnaptysBio, Inc.'s EPS (diluted)?
- Over 3 years (2021 to 2024), AnaptysBio, Inc.'s EPS (diluted) has grown at a 34.6% compound annual growth rate (CAGR), from -$2.11 to -$5.15.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about AnaptysBio, Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude